Awareness and treatment of hypertension in the United States has been
improving for older patients, but hypertension continues in many cases
to be poorly controlled. Three options exist if initial therapy fails
to achieve target blood pressure: upward drug titration, substituting
another drug, or combination drug therapy. Combination therapy is the
attempt to optimize blood pressure control by using two or more agent
s with additive or synergistic effects. Problems with this approach in
clude noncompliance due to complicated regimens, adverse drug reaction
s, and the added expense of multiple medications. However, the newer f
ixed-dose combination products have been shown to offer improved blood
pressure control, simplification of drug regimens, decreased adverse
reactions, improved compliance, and cost-effectiveness.